目前和新兴的安吉尔曼综合征治疗选择
Christopher J Keary1,2,3,4, Christopher J McDougle1,2,3
1Department is department of psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Expert review of neurotherapeutics
|August 21, 2023
概括
安吉尔曼综合征 (AS) 是一种罕见的神经发育障碍. 包括和行为问题在内的AS症状的理解和治疗方面的进展正在为基因疗法铺平道路.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 发育儿科 发育儿科
背景情况:
- 安吉尔曼综合征 (AS) 是一种遗传性神经发育障碍,由UBE3A基因脱节缺陷引起.
- 关键特征包括智力障碍,,运动缺陷和言语受限.
- 最近在理解AS的神经,行为和睡眠障碍方面取得了进展.
研究的目的:
- 审查目前对AS核心症状的理解和治疗方法.
- 考虑AS新兴基因疗法的潜力.
- 突出早期识别和行为干预的重要性.
主要方法:
- 对AS现象学研究的文献综述.
- 最近治疗进展的证据摘要.
- 考虑基因疗法的临床发展.
主要成果:
- 描述了的现象学和行为问题 (过度活跃,侵略性,自我伤害,重复行为,睡眠障碍).
- 审查了这些领域最近治疗进展的证据.
- 考虑了新兴基因疗法的潜力.
结论:
- 新兴的基因疗法为安吉尔曼综合征提供了新的希望.
- 早期和公平地识别AS至关重要.
- 行为疗法在管理AS症状,如侵略性和睡眠障碍方面发挥着至关重要的作用.
相关概念视频
Alzheimer's Disease: Treatment
213
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
213
Mania and Antimanic Drugs: Overview
233
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
233
Parkinson's Disease: Treatment
297
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
297
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Antiepileptic Drugs: Glutamate Antagonists
421
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
421
Gene Therapy
25.5K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.5K


